Assessment of Safety, Tolerability and Pharmacokinetics of Intravitreal Pegcetacoplan (APL-2) for Patients With Wet AMD
Clinical trial NCT02461771 · COMPLETED
Trial details
- NCT number
- NCT02461771
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-28
- Primary completion
- 2016-03-08
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.